1

News & Events

BiomX Raises $32 Million in Series B Financing

-- Proceeds will be used primarily to advance leading IBD and acne programs to the clinic -- Ness Ziona, Israel – February 20, 2019 – BiomX Ltd., a microbiome company developing customized phage therapies, today announced the closing of a $32 million...

read more

LEARN MORE ABOUT BIOMX MISSION FOR HEALTH

OUR INVESTORS